Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein - PubMed (original) (raw)
. 1997 Apr 14;230(2):217-27.
doi: 10.1006/viro.1997.8493.
Affiliations
- PMID: 9143277
- DOI: 10.1006/viro.1997.8493
Free article
Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
M J Gale Jr et al. Virology. 1997.
Free article
Abstract
Hepatitis C virus (HCV) is the major cause of non-A non-B hepatitis and a leading cause of liver dysfunction worldwide. While the current therapy for chronic HCV infection is parenteral administration of type 1 interferon (IFN), only a fraction of HCV-infected individuals completely respond to treatment. Previous studies have correlated the IFN sensitivity of strain HCV-1b with mutations within a discrete region of the viral nonstructural 5A protein (NS5A), termed the interferon sensitivity determining region (ISDR), suggesting that NS5A may contribute to the IFN-resistant phenotype of HCV. To determine the importance of HCV NS5A and the NS5A ISDR in mediating HCV IFN resistance, we tested whether the NS5A protein could regulate the IFN-induced protein kinase, PKR, a mediator of IFN-induced antiviral resistance and a target of viral and cellular inhibitors. Using multiple approaches, including biochemical, transfection, and yeast genetics analyses, we can now report that NS5A represses PKR through a direct interaction with the protein kinase catalytic domain and that both PKR repression and interaction requires the ISDR. Thus, inactivation of PKR may be one mechanism by which HCV avoids the antiviral effects of IFN. Finally the inhibition of the PKR protein kinase, by NS5A is the first described function for this HCV protein.
Similar articles
- Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
Gale MJ Jr, Korth MJ, Katze MG. Gale MJ Jr, et al. Clin Diagn Virol. 1998 Jul 15;10(2-3):157-62. doi: 10.1016/s0928-0197(98)00034-8. Clin Diagn Virol. 1998. PMID: 9741641 Review. - Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG. Gale M Jr, et al. J Virol. 1999 Aug;73(8):6506-16. doi: 10.1128/JVI.73.8.6506-6516.1999. J Virol. 1999. PMID: 10400746 Free PMC article. - Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
Gale M Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. Gale M Jr, et al. Mol Cell Biol. 1998 Sep;18(9):5208-18. doi: 10.1128/MCB.18.9.5208. Mol Cell Biol. 1998. PMID: 9710605 Free PMC article. - Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
Noguchi T, Satoh S, Noshi T, Hatada E, Fukuda R, Kawai A, Ikeda S, Hijikata M, Shimotohno K. Noguchi T, et al. Microbiol Immunol. 2001;45(12):829-40. doi: 10.1111/j.1348-0421.2001.tb01322.x. Microbiol Immunol. 2001. PMID: 11838900 - The non-structural 5A protein of hepatitis C virus.
Pawlotsky JM, Germanidis G. Pawlotsky JM, et al. J Viral Hepat. 1999 Sep;6(5):343-56. doi: 10.1046/j.1365-2893.1999.00185.x. J Viral Hepat. 1999. PMID: 10607250 Review.
Cited by
- Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations.
Yamauchi K, Maekawa S, Osawa L, Komiyama Y, Nakakuki N, Takada H, Muraoka M, Suzuki Y, Sato M, Takano S, Enomoto N. Yamauchi K, et al. J Gastroenterol. 2024 Nov;59(11):1021-1036. doi: 10.1007/s00535-024-02146-3. Epub 2024 Sep 3. J Gastroenterol. 2024. PMID: 39225750 - Hepatitis C Virus and Molecular Mimicry.
Goh L, Kerkar N. Goh L, et al. Pathogens. 2024 Jun 22;13(7):527. doi: 10.3390/pathogens13070527. Pathogens. 2024. PMID: 39057754 Free PMC article. Review. - CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.
Bunz M, Eisele M, Hu D, Ritter M, Kammerloher J, Lampl S, Schindler M. Bunz M, et al. Front Cell Infect Microbiol. 2024 Jan 31;14:1338606. doi: 10.3389/fcimb.2024.1338606. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38357447 Free PMC article. - Suppression of Innate Immunity by the Hepatitis C Virus (HCV): Revisiting the Specificity of Host-Virus Interactive Pathways.
Barik S. Barik S. Int J Mol Sci. 2023 Nov 8;24(22):16100. doi: 10.3390/ijms242216100. Int J Mol Sci. 2023. PMID: 38003289 Free PMC article. Review. - NS5A domain I antagonises PKR to facilitate the assembly of infectious hepatitis C virus particles.
Chen S, Harris M. Chen S, et al. PLoS Pathog. 2023 Feb 16;19(2):e1010812. doi: 10.1371/journal.ppat.1010812. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36795772 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases